ENTITY
Polaris Group

Polaris Group (6550 TT)

23
Analysis
Health CareTaiwan
Polaris Group of TW researches and develops biological drugs for cancer, small molecular drugs, and other diagnostic reagents. The Company focuses on hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, and acute myeloid leukemia fields. Polaris Group conducts businesses in Taiwan and California.
more
Event Icon
No events found
We’ll display events we find for Polaris Group here
x